Oistein Hovde
Overview
Explore the profile of Oistein Hovde including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
508
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zerouga I, Valeur J, Sommer C, Carlsen M, Hagen M, Hoivik M, et al.
Clin Nutr ESPEN
. 2025 Mar;
67:105-113.
PMID: 40064237
Purpose: Almost a third of patients with inactive inflammatory bowel disease (IBD) suffer from symptoms compatible with irritable bowel syndrome (IBS-like symptoms). The relation between these symptoms and diet in...
2.
Lund C, Strande V, Hagen M, Bengtson M, Boyar R, Detlie T, et al.
Inflamm Bowel Dis
. 2024 Dec;
PMID: 39699202
Background And Aims: The emergence of biologic therapy has coincided with a decline in surgery rates for Crohn's disease (CD). This study aims to describe the disease course, including intra-abdominal...
3.
Strande V, Lund C, Hagen M, Bengtson M, Cetinkaya R, Detlie T, et al.
Aliment Pharmacol Ther
. 2024 Jun;
60(3):357-368.
PMID: 38837289
Background: The introduction of biologic therapies and the 'treat-to-target' treatment strategy may have changed the disease course of ulcerative colitis (UC). Aims: To describe the early disease course and disease...
4.
Zerouga I, Valeur J, Sommer C, Smastuen M, Medhus A, Lund C, et al.
Scand J Gastroenterol
. 2024 Feb;
59(6):652-660.
PMID: 38356408
Background: Dietary recommendations in inflammatory bowel disease (IBD) are inconclusive, and patients may follow restrictive diets with increased risk of malnutrition. The aim of this study was to compare dietary...
5.
Follin-Arbelet B, Smastuen M, Hovde O, Jelsness-Jorgensen L, Moum B
Crohns Colitis 360
. 2023 Oct;
5(4):otad057.
PMID: 37886706
Background: Patients with Crohn's disease (CD) are most often diagnosed as young adults; therefore, long-term studies are needed to assess the risk of cancer over their lifetime. Thus, the aims...
6.
Vats A, Pedersen M, Mohammed A, Hovde O
Sci Rep
. 2023 Jul;
13(1):10857.
PMID: 37407635
Wireless Capsule Endoscopy (WCE) is being increasingly used as an alternative imaging modality for complete and non-invasive screening of the gastrointestinal tract. Although this is advantageous in reducing unnecessary hospital...
7.
Follin-Arbelet B, Smastuen M, Hovde O, Jelsness-Jorgensen L, Moum B
Scand J Gastroenterol
. 2023 Jun;
58(11):1264-1270.
PMID: 37337889
Objectives: Patients with ulcerative colitis (UC) have shown an increased risk for colorectal cancer, hepatobiliary, hematologic, and skin cancers, but updated long-term data is needed. This study aimed to estimate...
8.
Aass Holten K, Bernklev T, Opheim R, Johansen I, Olsen B, Lund C, et al.
J Crohns Colitis
. 2023 Jun;
17(11):1781-1790.
PMID: 37279652
Background And Aims: Although fatigue is common in inflammatory bowel disease [IBD], its pathogenesis remains unclear. This study aimed to determine the prevalence of fatigue and its associated factors in...
9.
Follin-Arbelet B, Smastuen M, Hovde O, Jelsness-Jorgensen L, Moum B
J Crohns Colitis
. 2022 Oct;
17(4):497-503.
PMID: 36239614
Background And Aims: Patients with longstanding inflammatory bowel disease [IBD] may be at an increased risk of death compared to the general population, especially elderly patients. The Inflammatory Bowel South-Eastern...
10.
Tejera V, Ohman L, Aabakken L, Fellstrom B, Hausken T, Hovde O, et al.
Aliment Pharmacol Ther
. 2022 Aug;
56(6):968-979.
PMID: 35942522
Background: Low-grade immune activation in the gut is a potential treatment target in irritable bowel syndrome (IBS). Aims: To determine improvement in IBS symptoms after mesalazine treatment, and the utility...